Monday, December 22, 2025
ADVT 
International

Starting Jan, 20k H-1B holders will be able to renew their visas in US

Darpan News Desk IANS, 29 Nov, 2023 03:13 PM
  • Starting Jan, 20k H-1B holders will be able to renew their visas in US

New York, Nov 29 (IANS) In a move likely to benefit Indian professionals, 20,000 H1B specialty occupation workers will be able to renew their visas in the US beginning from January next year, according to State Department officials.

This development comes months after the White House announced a pilot programme for domestic renewal of certain categories of H-1B visas during the state visit of Prime Minister Narendra Modi in June this year.

The visa renewal pilot programme is one of multiple measures the State Department is looking to add or continue with the aim of driving down wait times for travel to the US, Bloomberg Law reported, citing officials.

It would allow H-1B holders to renew their visas by mailing them to the State Department rather than travel outside the US and face uncertain wait times to secure an appointment at a US consular office before returning.

“We really need to get proof of concept that it works before we can extend it to a larger group,” Deputy Assistant Secretary for Consular Affairs Julie Stufft told reporters on Monday.

“This is a huge change for folks who live here and previously would have had to leave the US,” she added.

Due to heavy visa backlogs, some H-1B workers have pursued work-arounds such as traveling to nearby countries with fewer backlogs to secure appointments.

According to Stufft, the domestic renewal option would help consular offices in those countries as well as India.

The average wait time to secure a visa appointment for travel to the US fell to 130 days last year, a drop of 70 days from fiscal year 2022.

The State Department considers acceptable wait times to be closer to 90 days.

MORE International ARTICLES

Norad leaders call for 'layered defence'

Norad leaders call for 'layered defence'
Fesler and O'Shaughnessy say adversaries like Russia and China are increasingly well-positioned to exploit the "seams" that currently exist between North America's air, sea and missile defence systems and early warning networks.

Norad leaders call for 'layered defence'

Trump follows Biden to battleground Michigan

Trump follows Biden to battleground Michigan
Biden plans stiff tax penalties for companies that manufacture U.S.-bound products outside the country and a crackdown on those that use offshoring to avoid paying taxes at home.

Trump follows Biden to battleground Michigan

Biden in Michigan to talk Buy American

Biden in Michigan to talk Buy American
If elected, Biden said, he would impose stiff new tax penalties on companies that manufacture U.S.-bound products outside the country, create incentives for keeping jobs on U.S. soil and close what he called "Trump loopholes" that allow companies engaged in offshoring to avoid paying U.S. taxes.

Biden in Michigan to talk Buy American

AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject

AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject
A spokesperson for AstraZeneca, via a statement said that the company’s “standard review process triggered a pause to vaccination to allow review of safety data.”

AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject

Alleged neo-Nazi back in U.S. court Jan. 12

Alleged neo-Nazi back in U.S. court Jan. 12
Prosecutors, defence lawyers and District Judge Theodore Chuang gathered today via conference call to set deadlines for the government's response to the motions and to set a hearing date.

Alleged neo-Nazi back in U.S. court Jan. 12

Still too soon to try altering human embryo DNA, panel says

Still too soon to try altering human embryo DNA, panel says
Thursday’s report comes nearly two years after a Chinese scientist shocked the world by revealing he’d helped make the first gene-edited babies using a tool called CRISPR, which enables DNA changes or “edits” that can pass to future generations.

Still too soon to try altering human embryo DNA, panel says